B. Gino Fallone

Prof. Dr. B. Gino Fallone

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2009 in Medical Physics
Verified
Journal Article
Closed access
BFB. Gino Fallone
B. Gino Fallone
BMB. Murray
B. Murray
SRS. Rathee
S. Rathee
TST. Stanescu
T. Stanescu
SSS. Steciw
S. Steciw
DTD. Tymofichuk
D. Tymofichuk

1 July 2014 in Seminars in Radiation Oncology
Verified
Journal Article
Closed access
BFB. Gino Fallone
B. Gino Fallone

8 January 2007 in Medical Physics
Verified
Journal Article
Closed access
LBLesley N. Baldwin
Lesley N. Baldwin
KWKeith Wachowicz
Keith Wachowicz
STSteven D. Thomas
Steven D. Thomas
RRRyan Rivest
Ryan Rivest
BFB. Gino Fallone
B. Gino Fallone

15 April 2006 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SDSambasivarao Damaraju
Sambasivarao Damaraju
DMDavid Murray
David Murray
JDJennifer Dufour
Jennifer Dufour
DCDiana Carandang
Diana Carandang
SMSten Myrehaug
Sten Myrehaug
MPMatthew Parliament
Matthew Parliament
Objective: To explore the possible relationship between single nucleotide polymorphisms (SNP) in candidate genes encoding DNA damage recognition/repair/response and steroid metabolism proteins with respect to clinical radiation toxicity in a retrospective cohort of patients previously treated with three-dimensional conformal radiotherapy (3-DCRT) for prostate cancer. Experimental Design: One hundred twenty-four patients with prostate cancer underwent 3-DCRT at our institution between September 1996 and December 2000. Of these, 83 consented for follow-up of blood sampling and SNP analysis. Twenty-eight patients were documented as having experienced grade ≥2 late bladder or rectal toxicity (scoring system of Radiation Therapy Oncology Group) on at least one follow-up visit. We analyzed 49 SNPs in BRCA1, BRCA2, ESR1, XRCC1, XRCC2, XRCC3, NBN, RAD51, RAD52, LIG4, ATM, BCL2, TGFB1, MSH6, ERCC2, XPF, NR3C1, CYP1A1, CYP2C9, CYP2C19, CYP3A5, CYP2D6, CYP11B2, and CYP17A1 genes using the Pyrosequencing technique. Results: Significant univariate associations with late rectal or bladder toxicity (grade ≥2) were found for XRCC3 (A>G 5′ untranslated region NT 4541), LIG4 (T>C Asp568Asp), MLH1 (C>T, Val219Ile), CYP2D6*4 (G>A splicing defect), mean rectal and bladder dose, dose to 30% of rectum or bladder, and age C, Asp568Asp), ERCC2 (G>A, Asp711Asp), CYP2D6*4 (G>A, splicing defect), mean bladder dose >60 Gy, and dose to 30% of rectal volume >75 Gy. Conclusions: In this study, we identified SNPs in LIG4, ERCC2, and CYP2D6 genes as putative markers to predict individuals at risk for complications arising from radiation therapy in prostate cancer.

15 March 2013 in Medical Physics
Verified
Journal Article
Closed access
PDF file
MRM. Reynolds
M. Reynolds
BFB. Gino Fallone
B. Gino Fallone
SRS. Rathee
S. Rathee

17 June 2008 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
TST Stanescu
T Stanescu
HJH-S Jans
H-S Jans
NPN Pervez
N Pervez
PSPavel Stavrev
Pavel Stavrev
BFB. Gino Fallone
B. Gino Fallone
The aim of this study is to develop a magnetic resonance imaging (MRI)-based treatment planning procedure for intracranial lesions. The method relies on (a) distortion correction of raw magnetic resonance (MR) images by using an adaptive thresholding and iterative technique, (b) autosegmentation of head structures relevant to dosimetric calculations (scalp, bone and brain) using an atlas-based software and (c) conversion of MR images into computed tomography (CT)-like images by assigning bulk CT values to organ contours and dose calculations performed in Eclipse (Philips Medical Systems). Standard CT + MRI-based and MRI-only plans were compared by means of isodose distributions, dose volume histograms and several dosimetric parameters. The plans were also ranked by using a tumor control probability (TCP)-based technique for heterogeneous irradiation, which is independent of radiobiological parameters. For our 3 T Intera MRI scanner (Philips Medical Systems), we determined that the total maximum image distortion corresponding to a typical brain study was about 4 mm. The CT + MRI and MRI-only plans were found to be in good agreement for all patients investigated. Following our clinical criteria, the TCP-based ranking tool shows no significant difference between the two types of plans. This indicates that the proposed MRI-based treatment planning procedure is suitable for the radiotherapy of intracranial lesions.